Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trial.
暂无分享，去创建一个
T. Conroy | J. Douillard | V. Boige | O. Bouché | S. Gourgou-Bourgade | J. Raoul | P. Michel | A. Adenis | L. Bedenne | G. Créhange | E. François | M. Galais | I. Martel-Lafay | B. Juzyna | P. Etienne | M. B. Abdelghani | C. Llacer-Moscardo